[
  {
    "ts": null,
    "headline": "How Analyst Outlooks Are Shaping the Evolving Story for IDEXX Laboratories",
    "summary": "IDEXX Laboratories has recently seen its Fair Value Estimate decrease from $695.09 to $679.92. This reflects a modest downward adjustment in the company’s projected value. This change comes as revenue growth expectations are slightly tempered, even as the company continues to deliver strong performance in key business areas. Stay tuned to discover how these nuanced adjustments shape the evolving narrative for IDEXX Laboratories and what you can do to keep informed as the story develops. What...",
    "url": "https://finnhub.io/api/news?id=0969f8bedc095eb0f52178e9aeb64167e92f8bd5b926b18b4753ab000deeefd2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760940338,
      "headline": "How Analyst Outlooks Are Shaping the Evolving Story for IDEXX Laboratories",
      "id": 137165360,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories has recently seen its Fair Value Estimate decrease from $695.09 to $679.92. This reflects a modest downward adjustment in the company’s projected value. This change comes as revenue growth expectations are slightly tempered, even as the company continues to deliver strong performance in key business areas. Stay tuned to discover how these nuanced adjustments shape the evolving narrative for IDEXX Laboratories and what you can do to keep informed as the story develops. What...",
      "url": "https://finnhub.io/api/news?id=0969f8bedc095eb0f52178e9aeb64167e92f8bd5b926b18b4753ab000deeefd2"
    }
  }
]